Minneapolis Heart Institute Foundation First Site Worldwide to Randomize Patient in ReCor Medical’s RADIANCE-II Study

Minneapolis Heart Institute Foundation First Site Worldwide to Randomize Patient in ReCor Medical’s RADIANCE-II Study

As reported directly by the Minneapolis Heart Institute, this study represents a pivotal randomized blinded study of sponsor’s Recor’s Paradise® Ultrasound Denervation System for the treatment of high blood pressure. TrialSite News reviewed the study published in...

Pin It on Pinterest